US mobile operator AT&T has granted medical device vendor PositiveID access to its network so that it can transmit blood glucose readings from diabetes patients to the vendor’s portal via the operator’s cellular network. The US vendor announced that its FDA-cleared iglucose system has received certification from AT&T. The system is intended to communicate readings from a glucometer to PositiveID’s diabetes management portal so that the data can be shared with family, friends and healthcare providers.  The system also includes a wireless-enabled device (pictured) that uploads readings from the glucometer to the portal.

The iglucose system is not yet commercially available although PositiveID’s chairman and CEO William J Caragol said its roll-out was planned for early this year through pilots with insurers and home-healthcare providers.  PositiveID's announcement says the AT&T network has “the largest global presence of any US-based wireless provider” although the vendor does not give an indication of where it plans to launch the iglucose system outside the US (where it has FDA clearance).